Bio Rad Revenue vs. Price To Book

BIO-B Stock  USD 337.08  0.00  0.00%   
Based on the measurements of profitability obtained from Bio Rad's financial statements, Bio Rad Laboratories may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Bio Rad's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
1985-09-30
Previous Quarter
638.5 M
Current Value
649.7 M
Quarterly Volatility
228.7 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
At present, Bio Rad's Price To Sales Ratio is projected to slightly grow based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 87.31, whereas Operating Cash Flow Sales Ratio is forecasted to decline to 0.08. At present, Bio Rad's Operating Income is projected to increase significantly based on the last few years of reporting. The current year's Non Operating Income Net Other is expected to grow to about 54.1 M, whereas Accumulated Other Comprehensive Income is projected to grow to (319.2 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.630.5358
Fairly Up
Pretty Stable
For Bio Rad profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bio Rad to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bio Rad Laboratories utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bio Rad's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bio Rad Laboratories over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bio Rad Laboratories Price To Book vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Bio Rad's current stock value. Our valuation model uses many indicators to compare Bio Rad value to that of its competitors to determine the firm's financial worth.
Bio Rad Laboratories is rated third in revenue category among its peers. It is rated below average in price to book category among its peers . The ratio of Revenue to Price To Book for Bio Rad Laboratories is about  2,119,544,553 . At present, Bio Rad's Total Revenue is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bio Rad's earnings, one of the primary drivers of an investment's value.

Bio Revenue vs. Competition

Bio Rad Laboratories is rated third in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 19.62 Billion. Bio Rad retains roughly 2.67 Billion in revenue claiming about 14% of equities under Health Care industry.

Bio Price To Book vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Bio Rad

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
2.67 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Bio Rad

P/B

 = 

MV Per Share

BV Per Share

 = 
1.26 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

Bio Price To Book Comparison

Bio Rad is currently under evaluation in price to book category among its peers.

Bio Rad Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Bio Rad, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bio Rad will eventually generate negative long term returns. The profitability progress is the general direction of Bio Rad's change in net profit over the period of time. It can combine multiple indicators of Bio Rad, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-336 M-319.2 M
Operating Income365.7 M384 M
Income Before Tax-850.1 M-807.6 M
Total Other Income Expense Net-1.2 B-1.2 B
Net Loss-637.3 M-605.5 M
Income Tax Expense-212.8 M-202.1 M
Net Loss-159.3 M-151.3 M
Non Operating Income Net Other51.5 M54.1 M
Net Loss-4.2 B-4 B
Net Interest Income47.6 M50 M
Interest Income96.4 M101.2 M
Change To Netincome4.7 BB
Net Loss(21.82)(20.73)
Income Quality(0.59)(0.56)
Net Income Per E B T 0.75  0.58 

Bio Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Bio Rad. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bio Rad position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bio Rad's important profitability drivers and their relationship over time.

Use Bio Rad in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Bio Rad Pair Trading

Bio Rad Laboratories Pair Trading Analysis

The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Bio Rad position

In addition to having Bio Rad in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Growth Funds Thematic Idea Now

Small Growth Funds
Small Growth Funds Theme
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
To fully project Bio Rad's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bio Rad Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bio Rad's income statement, its balance sheet, and the statement of cash flows.
Potential Bio Rad investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Bio Rad investors may work on each financial statement separately, they are all related. The changes in Bio Rad's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bio Rad's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.